(Q40067841)

17 September 2017

Lithium-induced thyroid disturbance: case report and review (English)

1 reference

17 September 2017

Lithium-induced thyroid disturbance: Case report and review (English)

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

3 July 2023

author name string

B. Shopsin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5820094

3 July 2023

M. Blum

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5820094

3 July 2023

S. Gershon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5820094

3 July 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5820094

3 July 2023

publication date

1 May 1969

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0010440X69900352?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

https://api.elsevier.com/content/article/PII:0010440X69900352?httpAccept=text/plain

3 July 2023

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

3 July 2023

published in

Comprehensive Psychiatry

1 reference

17 September 2017

10

1 reference

17 September 2017

3

1 reference

17 September 2017

215-223

1 reference

Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis

17 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

Iodoamino acid distribution in the serum of schizophrenic patients receiving perphenazine

3 July 2023

8

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

TWO-YEAR FOLLOW-UP STUDY OF PROTEIN-BOUND IODINE ELEVATION IN PATIENTS RECEIVING PERPHENAZINE

3 July 2023

9

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

The possible thymoleptic effect of the lithium ion.

3 July 2023

13

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

Lithium ion: a specific psychopharmacological approach to the treatment of mania

3 July 2023

14

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

THE USE OF LITHIUM SALTS IN AFFECTIVE DISORDERS

3 July 2023

20

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

Methods for the qualitative, semiquantitative and quantitative determination of iodoamino acids and of inorganic iodide in iodoprotein digests and in human serum

3 July 2023

25

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

Retention of radioiodine by salivary glands

3 July 2023

27

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

FURTHER REPORT ON PROTEIN-BOUND IODINE IN PATIENTS RECEIVING PERPHENAZINE

3 July 2023

28

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

Occurrence of goitre during lithium treatment.

3 July 2023

31

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

The treatment of manic psychoses by the administration of lithium salts

3 July 2023

32

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

Materials Indistinguishable from Iodotyrosines in Normal Human Serum and Human Serum Albumin*

3 July 2023

34

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

The use of lithium in the affective psychoses

3 July 2023

35

1 reference

https://api.crossref.org/works/10.1016/0010-440X(69)90035-2

3 July 2023

Identifiers

1 reference

17 September 2017

1 reference